黄芪多糖联合放疗对小鼠H22肝癌移植瘤的放射增敏及免疫功能的影响*
作者:
作者单位:

泰山医学院附属莱钢医院,山东 莱芜 271126

作者简介:

通讯作者:

中图分类号:

R735.7

基金项目:

* 基金项目: 山东省保健科技协会课题(2016BJ0014)
收稿日期: 2017 - 11- 13
作者简介: 吕心明(1972-),男,山东莱芜人,主管技师,研究方向:肿瘤放疗的研究。
△通信作者: 闫呈新,E-mail:petct001@163.com


Effect of Astragalus Polysaccharide Combined with Radiotherapy on Radiosensitivityand Immune Function of Transplanted Tumor in Mice
Author:
Affiliation:

Lai-Gang Hospital Affiliated to Taishan Medical College, Laiwu 271126, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的 探讨黄芪多糖联合放疗对小鼠H22肝癌皮下移植瘤的放射增敏作用及免疫功能的影响。方法 建立小鼠H22移植瘤模型,将50只小鼠分为A组(对照组)、B组(化疗组)、C组(低剂量黄芪多糖联合化疗组)、D组(中剂量联合化疗组)、E组(高剂量联合化疗组),观察各组小鼠肿瘤生长情况及免疫功能变化。结果 随着联合黄芪多糖药物浓度的增加,肿瘤3倍倍增时间(TGT3)、肿瘤生长延迟时间(TGD)以及增敏系数(EF)值均有所增加;治疗14d,各治疗组小鼠瘤体重量均显著低于A组,且E组小鼠瘤体重量明显低于其他各组(P<0.05),随着黄芪多糖药物浓度的增加,抑瘤率越高;各治疗组小鼠平均生存期均显著长于A组(P<0.05),且随着联合运用黄芪多糖药物浓度的增加,小鼠平均生存期和生命延长率显著增加(P<0.05);各治疗组小鼠免疫功能各指标均较A组显著降低(P<0.05)。结论 黄芪多糖联合放疗有增敏作用,能够抑制肿瘤生长,延长移植瘤小鼠生存期,提高小鼠的免疫功能,有一定的剂量依赖。

    Abstract:

    Objective To explore the effects of astragalus polysaccharide combined with radiotherapy on radiosensitization of H22 transplanted hepatocarcinoma and immunologic function in mice. Methods Establishment of mouse H22 transplanted tumor model, 50 mice were divided into A group(control group), B group(chemotherapy group), group C(low dose of Astragalus Polysaccharides combined with chemotherapy group), group D(middle dose chemotherapy group), E group(Gao Jiliang chemotherapy group), the growth situation and change observation on the immune function of tumor mice. Results With the increase of drug concentration combined with astragalus polysaccharide, TGT3, TGD and EF values were increased; treatment of 14d, the tumor weight of mice in treatment group were lower than A group and E group, and lower than the other groups, with the increase of drug concentration of Astragalus, the inhibition rate is higher; the average survival period of all treatment groups were longer than that of group A, and with the increase of drug combined with astragalus; the index of immune function in mice in each treatment group were lower than those in A group, and the combined use of Astragalus polysaccharide. Conclusion Astragalus polysaccharide combined with radiotherapy has radiosensitizing effect, can inhibit tumor growth, prolong the survival time of mice with transplanted tumor and increase the immunological function of mice.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:

温馨提示

关闭